Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 5
Submit an article Journal homepage
307
Views
10
CrossRef citations to date
0
Altmetric
Review

Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples

Maarten J Postma Unit of PharmacoEpidemiology and PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands. [email protected]; Unit of PharmacoEpidemiology and PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands. [email protected]
,
Tjalke A Westra Unit of PharmacoEpidemiology and PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Unit of PharmacoEpidemiology and PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands
,
Sibilia Quilici Sanofi Pasteur MSD, Lyon, France; Sanofi Pasteur MSD, Lyon, France
&
Nathalie Largeron Sanofi Pasteur MSD, Lyon, France; Sanofi Pasteur MSD, Lyon, France
Pages 555-565 | Published online: 09 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Oscar Javier Maldonado Castañeda. (2017) Price-effectiveness: pharmacoeconomics, value and the right price for HPV vaccines. Journal of Cultural Economy 10:2, pages 163-177.
Read now
Carla D Scarbrough Lefebvre, Augustin Terlinden & Baudouin Standaert. (2015) Dissecting the indirect effects caused by vaccines into the basic elements. Human Vaccines & Immunotherapeutics 11:9, pages 2142-2157.
Read now
Matthew J Robbins & Sheldon H Jacobson. (2015) Analytics for vaccine economics and pricing: insights and observations. Expert Review of Vaccines 14:4, pages 605-616.
Read now

Articles from other publishers (7)

Gizem M. Bilgin, Syarifah Liza Munira, Kamalini Lokuge & Kathryn Glass. (2023) Cost-effectiveness analysis of a maternal pneumococcal vaccine in low-income, high-burden settings such as Sierra Leone. PLOS Global Public Health 3:8, pages e0000915.
Crossref
Ellen R. S. Rafferty, Heather L. Gagnon, Marwa Farag & Cheryl L. Waldner. (2017) Economic evaluations of vaccines in Canada: a scoping review. Cost Effectiveness and Resource Allocation 15:1.
Crossref
Bernhard Ultsch, Oliver Damm, Philippe Beutels, Joke Bilcke, Bernd Brüggenjürgen, Andreas Gerber-Grote, Wolfgang Greiner, Germaine Hanquet, Raymond Hutubessy, Mark Jit, Mirjam Knol, Rüdiger von Kries, Alexander Kuhlmann, Daniel Levy-Bruhl, Matthias Perleth, Maarten Postma, Heini Salo, Uwe Siebert, Jürgen Wasem & Ole Wichmann. (2015) Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics 34:3, pages 227-244.
Crossref
Mark Jit & Walter Mibei. (2015) Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review. Vaccine 33:32, pages 3788-3794.
Crossref
Edward Mezones-Holguin, Carlos Canelo-Aybar, Andrew David Clark, Cara Bess Janusz, Bárbara Jaúregui, Seimer Escobedo-Palza, Adrian V. Hernandez, Denhiking Vega-Porras, Marco González, Fabián Fiestas, Washington Toledo, Fabiana Michel & Víctor J. Suárez. (2015) Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru. Vaccine 33, pages A154-A166.
Crossref
Michael Pfleiderer & Ole Wichmann. (2015) Von der Zulassung von Impfstoffen zur Empfehlung durch die Ständige Impfkommission in DeutschlandFrom the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 58:3, pages 263-273.
Crossref
Maarten J Postma, Geert Top & Erik Buskens. (2013) Healthy aging through lifelong vaccination: a tale of two countries. Aging Health 9:6, pages 619-627.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.